跳至主要内容
临床试验/NCT05025124
NCT05025124已完成不适用

Entia Liberty: Analytical Performance Validation - Accuracy and Precision

Entia Ltd1 个研究点 分布在 1 个国家目标入组 530 人开始时间: 2022年10月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Entia Ltd
入组人数
530
试验地点
1
主要终点
To obtain the Total Error per parameter from the results of the Entia Liberty device

研究概览

简要总结

This study forms part of Entia's clinical evidence for regulatory submission. This study evaluates Entia Liberty's performance claims with venous blood compared to the gold standard clinical laboratory haematology analysers. Excess blood flagged by the laboratory meeting our requirements will be tested on the Entia Liberty device and have its results compared against the laboratory results. Samples will also be flagged for precision testing (same blood sample, split into 10 Entia Liberty samples).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years old
  • Currently receiving standard of care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy and has received at least one cycle
  • Blood samples that have been stored in K2-EDTA vacutainers only
  • For Accuracy testing: Samples covering 75% of parameter ranges (Neutrophils: 0.5-7.5 x 109/L, Platelets: 20-450 x 109/L, Haemoglobin: 70-180 g/L), These will be determined by a gold standard analyser which has been recently calibrated.
  • Reliability study: Level range per parameter. These will be determined by a gold standard analyser which has been recently calibrated.
  • Neutrophils (We assume WBC to behave similarly in the same ranges) Low: 0.5-1.2 x 109/L (3 samples), 1.2-2 x 109/L (2 samples) Normal: 2-7 x 109/L (3-4 samples) High: 7-12 x 109/L (1-2 samples)
  • Platelets Low: 50-150 x 109/L (5 samples) Normal: 150-400 x 109/L (3 - 4 samples) High: >400 x 109/L (1-2 samples)
  • Haemoglobin Low: <120 g/L (5 samples) Normal: 120-170 g/L (3 - 4 samples) High: >170 g/L (1-2 samples)

排除标准

  • History of haematological malignancy

结局指标

主要结局

To obtain the Total Error per parameter from the results of the Entia Liberty device

时间窗: 3 months

The dataset from this study will provide evidence to support the device's performance claims.

To obtain the precision per parameter from the results of the Entia Liberty device

时间窗: 3 months

The dataset from this study will provide evidence to support the device's performance claims.

To obtain the bias per parameter from the results of the Entia Liberty device

时间窗: 3 months

The dataset from this study will provide evidence to support the device's performance claims.

To obtain the linearity per parameter from the results of the Entia Liberty device

时间窗: 3 months

The dataset from this study will provide evidence to support the device's performance claims.

次要结局

未报告次要终点

研究者

发起方
Entia Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验